Loading…
IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors
Co-administration of IL-12 with vaccine immunogens has proven to be an effective strategy for eliciting potent Th1-biased immunity. Unfortunately, the use of IL-12 as a vaccine component has been limited because it is unstable at ambient temperatures, expensive to produce, and toxic when administere...
Saved in:
Published in: | Vaccine 2006-02, Vol.24 (9), p.1451-1461 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c490t-91ce54c795938a60ad6b59f525ee21bd5264499ae52ed24618660ba08721e79e3 |
---|---|
cites | |
container_end_page | 1461 |
container_issue | 9 |
container_start_page | 1451 |
container_title | Vaccine |
container_volume | 24 |
creator | Klas, Sheri D. Lavine, Christy L. Whitt, Michael A. Miller, Mark A. |
description | Co-administration of IL-12 with vaccine immunogens has proven to be an effective strategy for eliciting potent Th1-biased immunity. Unfortunately, the use of IL-12 as a vaccine component has been limited because it is unstable at ambient temperatures, expensive to produce, and toxic when administered at excessive dosages. Using reverse genetics, we created a recombinant replication-restricted vesicular stomatitis virus that expresses large quantities of an IL-12 fusion protein (VSVΔG-IL12F), but can only establish a single round of infection because the genome does not encode the viral glycoprotein (G protein) that is required for viral entry into host cells. Here, we report that immunization of mice with a poorly immunogenic listerial antigen preparation (LMAg) in combination with VSVΔG-IL12F elicits potent T cell- and B cell-mediated responses that confer protective listerial immunity. |
doi_str_mv | 10.1016/j.vaccine.2005.05.046 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19814769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X05009746</els_id><sourcerecordid>19814769</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-91ce54c795938a60ad6b59f525ee21bd5264499ae52ed24618660ba08721e79e3</originalsourceid><addsrcrecordid>eNqFkFGL1DAQx4Mo3t7pR1D6om9ZkzRJmyeRQ8-DBR_Uw7eQprNLljZZM-3C-elN3cI9CgMJ5PefmfwIecPZljOuPxy3Z-d9iLAVjKntUlI_IxveNjUVirfPyYYJLank7NcVuUY8sgLW3LwkV1zXnAkjNyTc7ygX1CEGnKCvwjjOMfxxU0ixcgcXIk7VbnnLwVVjisk_TukAEbCaMcRDleE0BP8vQDPglINfGj18f6Cdw3I7g59Sxlfkxd4NCK_X84b8_PL5x-1Xuvt2d3_7aUe9NGyihntQ0jdGmbp1mrled8rslVAAgne9Kn-SxjhQAnohNW-1Zp1jbSM4NAbqG_L-0veU0--5LGTHgB6GwUVIM1puWi4bbQqoLqDPCTHD3p5yGF1-tJzZxbE92tWxXRzbpaQuubfrgLkboX9KrVIL8G4FHHo37LOLPuAT16imLnDhPl44KDrOAbJFHyB66EMuzmyfwn9W-Qvtfp4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19814769</pqid></control><display><type>article</type><title>IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors</title><source>Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)</source><creator>Klas, Sheri D. ; Lavine, Christy L. ; Whitt, Michael A. ; Miller, Mark A.</creator><creatorcontrib>Klas, Sheri D. ; Lavine, Christy L. ; Whitt, Michael A. ; Miller, Mark A.</creatorcontrib><description>Co-administration of IL-12 with vaccine immunogens has proven to be an effective strategy for eliciting potent Th1-biased immunity. Unfortunately, the use of IL-12 as a vaccine component has been limited because it is unstable at ambient temperatures, expensive to produce, and toxic when administered at excessive dosages. Using reverse genetics, we created a recombinant replication-restricted vesicular stomatitis virus that expresses large quantities of an IL-12 fusion protein (VSVΔG-IL12F), but can only establish a single round of infection because the genome does not encode the viral glycoprotein (G protein) that is required for viral entry into host cells. Here, we report that immunization of mice with a poorly immunogenic listerial antigen preparation (LMAg) in combination with VSVΔG-IL12F elicits potent T cell- and B cell-mediated responses that confer protective listerial immunity.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2005.05.046</identifier><identifier>PMID: 16310294</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adjuvants, Immunologic - administration & dosage ; Adjuvants, Immunologic - genetics ; Adjuvants, Immunologic - pharmacology ; Animals ; Antibodies, Bacterial - blood ; Applied microbiology ; Bacterial Vaccines - immunology ; Bacteriology ; Biological and medical sciences ; Cells, Cultured ; Female ; Fundamental and applied biological sciences. Psychology ; Genetic Vectors ; IL-12 ; Interferon-gamma - biosynthesis ; Interleukin-12 - genetics ; Interleukin-12 - pharmacology ; Interleukin-2 - biosynthesis ; Listeria monocytogenes ; Listeria monocytogenes - immunology ; Listeriosis - immunology ; Listeriosis - pathology ; Listeriosis - prevention & control ; Liver - microbiology ; Lymphocytes - immunology ; Membrane Glycoproteins - genetics ; Mice ; Mice, Inbred C3H ; Microbiology ; Miscellaneous ; Recombinant Fusion Proteins ; Rodent ; Spleen - microbiology ; Vaccination ; Vaccination - methods ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Vesicular stomatitis Indiana virus - genetics ; Vesicular stomatitis Indiana virus - immunology ; Vesicular stomatitis Indiana virus - physiology ; Vesicular stomatitis virus ; Viral Envelope Proteins - genetics ; Virus Replication</subject><ispartof>Vaccine, 2006-02, Vol.24 (9), p.1451-1461</ispartof><rights>2005 Elsevier Ltd</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-91ce54c795938a60ad6b59f525ee21bd5264499ae52ed24618660ba08721e79e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17573163$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16310294$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Klas, Sheri D.</creatorcontrib><creatorcontrib>Lavine, Christy L.</creatorcontrib><creatorcontrib>Whitt, Michael A.</creatorcontrib><creatorcontrib>Miller, Mark A.</creatorcontrib><title>IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Co-administration of IL-12 with vaccine immunogens has proven to be an effective strategy for eliciting potent Th1-biased immunity. Unfortunately, the use of IL-12 as a vaccine component has been limited because it is unstable at ambient temperatures, expensive to produce, and toxic when administered at excessive dosages. Using reverse genetics, we created a recombinant replication-restricted vesicular stomatitis virus that expresses large quantities of an IL-12 fusion protein (VSVΔG-IL12F), but can only establish a single round of infection because the genome does not encode the viral glycoprotein (G protein) that is required for viral entry into host cells. Here, we report that immunization of mice with a poorly immunogenic listerial antigen preparation (LMAg) in combination with VSVΔG-IL12F elicits potent T cell- and B cell-mediated responses that confer protective listerial immunity.</description><subject>Adjuvants, Immunologic - administration & dosage</subject><subject>Adjuvants, Immunologic - genetics</subject><subject>Adjuvants, Immunologic - pharmacology</subject><subject>Animals</subject><subject>Antibodies, Bacterial - blood</subject><subject>Applied microbiology</subject><subject>Bacterial Vaccines - immunology</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Cells, Cultured</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetic Vectors</subject><subject>IL-12</subject><subject>Interferon-gamma - biosynthesis</subject><subject>Interleukin-12 - genetics</subject><subject>Interleukin-12 - pharmacology</subject><subject>Interleukin-2 - biosynthesis</subject><subject>Listeria monocytogenes</subject><subject>Listeria monocytogenes - immunology</subject><subject>Listeriosis - immunology</subject><subject>Listeriosis - pathology</subject><subject>Listeriosis - prevention & control</subject><subject>Liver - microbiology</subject><subject>Lymphocytes - immunology</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Mice</subject><subject>Mice, Inbred C3H</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Recombinant Fusion Proteins</subject><subject>Rodent</subject><subject>Spleen - microbiology</subject><subject>Vaccination</subject><subject>Vaccination - methods</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Vesicular stomatitis Indiana virus - genetics</subject><subject>Vesicular stomatitis Indiana virus - immunology</subject><subject>Vesicular stomatitis Indiana virus - physiology</subject><subject>Vesicular stomatitis virus</subject><subject>Viral Envelope Proteins - genetics</subject><subject>Virus Replication</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqFkFGL1DAQx4Mo3t7pR1D6om9ZkzRJmyeRQ8-DBR_Uw7eQprNLljZZM-3C-elN3cI9CgMJ5PefmfwIecPZljOuPxy3Z-d9iLAVjKntUlI_IxveNjUVirfPyYYJLank7NcVuUY8sgLW3LwkV1zXnAkjNyTc7ygX1CEGnKCvwjjOMfxxU0ixcgcXIk7VbnnLwVVjisk_TukAEbCaMcRDleE0BP8vQDPglINfGj18f6Cdw3I7g59Sxlfkxd4NCK_X84b8_PL5x-1Xuvt2d3_7aUe9NGyihntQ0jdGmbp1mrled8rslVAAgne9Kn-SxjhQAnohNW-1Zp1jbSM4NAbqG_L-0veU0--5LGTHgB6GwUVIM1puWi4bbQqoLqDPCTHD3p5yGF1-tJzZxbE92tWxXRzbpaQuubfrgLkboX9KrVIL8G4FHHo37LOLPuAT16imLnDhPl44KDrOAbJFHyB66EMuzmyfwn9W-Qvtfp4A</recordid><startdate>20060227</startdate><enddate>20060227</enddate><creator>Klas, Sheri D.</creator><creator>Lavine, Christy L.</creator><creator>Whitt, Michael A.</creator><creator>Miller, Mark A.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T5</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope></search><sort><creationdate>20060227</creationdate><title>IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors</title><author>Klas, Sheri D. ; Lavine, Christy L. ; Whitt, Michael A. ; Miller, Mark A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-91ce54c795938a60ad6b59f525ee21bd5264499ae52ed24618660ba08721e79e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adjuvants, Immunologic - administration & dosage</topic><topic>Adjuvants, Immunologic - genetics</topic><topic>Adjuvants, Immunologic - pharmacology</topic><topic>Animals</topic><topic>Antibodies, Bacterial - blood</topic><topic>Applied microbiology</topic><topic>Bacterial Vaccines - immunology</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Cells, Cultured</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetic Vectors</topic><topic>IL-12</topic><topic>Interferon-gamma - biosynthesis</topic><topic>Interleukin-12 - genetics</topic><topic>Interleukin-12 - pharmacology</topic><topic>Interleukin-2 - biosynthesis</topic><topic>Listeria monocytogenes</topic><topic>Listeria monocytogenes - immunology</topic><topic>Listeriosis - immunology</topic><topic>Listeriosis - pathology</topic><topic>Listeriosis - prevention & control</topic><topic>Liver - microbiology</topic><topic>Lymphocytes - immunology</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Mice</topic><topic>Mice, Inbred C3H</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Recombinant Fusion Proteins</topic><topic>Rodent</topic><topic>Spleen - microbiology</topic><topic>Vaccination</topic><topic>Vaccination - methods</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Vesicular stomatitis Indiana virus - genetics</topic><topic>Vesicular stomatitis Indiana virus - immunology</topic><topic>Vesicular stomatitis Indiana virus - physiology</topic><topic>Vesicular stomatitis virus</topic><topic>Viral Envelope Proteins - genetics</topic><topic>Virus Replication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klas, Sheri D.</creatorcontrib><creatorcontrib>Lavine, Christy L.</creatorcontrib><creatorcontrib>Whitt, Michael A.</creatorcontrib><creatorcontrib>Miller, Mark A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klas, Sheri D.</au><au>Lavine, Christy L.</au><au>Whitt, Michael A.</au><au>Miller, Mark A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2006-02-27</date><risdate>2006</risdate><volume>24</volume><issue>9</issue><spage>1451</spage><epage>1461</epage><pages>1451-1461</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Co-administration of IL-12 with vaccine immunogens has proven to be an effective strategy for eliciting potent Th1-biased immunity. Unfortunately, the use of IL-12 as a vaccine component has been limited because it is unstable at ambient temperatures, expensive to produce, and toxic when administered at excessive dosages. Using reverse genetics, we created a recombinant replication-restricted vesicular stomatitis virus that expresses large quantities of an IL-12 fusion protein (VSVΔG-IL12F), but can only establish a single round of infection because the genome does not encode the viral glycoprotein (G protein) that is required for viral entry into host cells. Here, we report that immunization of mice with a poorly immunogenic listerial antigen preparation (LMAg) in combination with VSVΔG-IL12F elicits potent T cell- and B cell-mediated responses that confer protective listerial immunity.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>16310294</pmid><doi>10.1016/j.vaccine.2005.05.046</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2006-02, Vol.24 (9), p.1451-1461 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_proquest_miscellaneous_19814769 |
source | Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list) |
subjects | Adjuvants, Immunologic - administration & dosage Adjuvants, Immunologic - genetics Adjuvants, Immunologic - pharmacology Animals Antibodies, Bacterial - blood Applied microbiology Bacterial Vaccines - immunology Bacteriology Biological and medical sciences Cells, Cultured Female Fundamental and applied biological sciences. Psychology Genetic Vectors IL-12 Interferon-gamma - biosynthesis Interleukin-12 - genetics Interleukin-12 - pharmacology Interleukin-2 - biosynthesis Listeria monocytogenes Listeria monocytogenes - immunology Listeriosis - immunology Listeriosis - pathology Listeriosis - prevention & control Liver - microbiology Lymphocytes - immunology Membrane Glycoproteins - genetics Mice Mice, Inbred C3H Microbiology Miscellaneous Recombinant Fusion Proteins Rodent Spleen - microbiology Vaccination Vaccination - methods Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Vesicular stomatitis Indiana virus - genetics Vesicular stomatitis Indiana virus - immunology Vesicular stomatitis Indiana virus - physiology Vesicular stomatitis virus Viral Envelope Proteins - genetics Virus Replication |
title | IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T09%3A48%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IL-12-assisted%20immunization%20against%20Listeria%20monocytogenes%20using%20replication-restricted%20VSV-based%20vectors&rft.jtitle=Vaccine&rft.au=Klas,%20Sheri%20D.&rft.date=2006-02-27&rft.volume=24&rft.issue=9&rft.spage=1451&rft.epage=1461&rft.pages=1451-1461&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2005.05.046&rft_dat=%3Cproquest_cross%3E19814769%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c490t-91ce54c795938a60ad6b59f525ee21bd5264499ae52ed24618660ba08721e79e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19814769&rft_id=info:pmid/16310294&rfr_iscdi=true |